Koiwa, Fumihiko
Yazawa, Rie
Fukagawa, Masafumi
Honda, Daisuke http://orcid.org/0000-0001-5624-7553
Akizawa, Tadao
Article History
Accepted: 7 February 2022
First Online: 25 March 2022
Declartions
:
: SKK sponsored this study. SKK paid the Open Access fee for this article.
: Fumihiko Koiwa and Masafumi Fukagawa received honoraria from SKK for consulting and lectures. Daisuke Honda is an employee of SKK. Tadao Akizawa received consulting fees from SKK.
: The study was conducted at SOUSEIKAI Sumida Hospital, Tokyo, Japan. All the study protocols and informed consent documents were reviewed and approved by the Japanese Pharmaceuticals and Medical Devices Agency and the investigation review board of the Hakata Clinic. This study was conducted in compliance with the Helsinki Declaration and comparable ethical standards, Good Clinical Practice guidelines, and other regulatory requirements.
: The dataset from this study is not available in any open data repository.
: Not applicable.
: All participants provided written informed consent before participating in the study.
: Not applicable.
: Fumihiko Koiwa, Rie Yazawa, and Tadao Akizawa substantially contributed to the study design and the acquisition and interpretation of the data. Masafumi Fukagawa and Daisuke Honda substantially contributed to the analysis and interpretation of data. All authors critically revised the report, commented on drafts of the manuscript, and approved the final report.